AVENCELL Trademark

Trademark Overview


On Monday, January 30, 2023, a trademark application was filed for AVENCELL with the United States Patent and Trademark Office. The USPTO has given the AVENCELL trademark a serial number of 97773407. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, July 16, 2024. This trademark is owned by AvenCell Therapeutics, Inc.. The AVENCELL trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical and biological preparations for the treatment of cancer and autoimmune diseases; pharmaceutical and biological preparations based on gene, genome, and cellular editing, modulation, and modification for use in human therapeutics for the treatment of cancer and autoimmune diseases; pharmaceutical preparations, namely, T-cell based therapeutics to treat cancer and autoimmune disease

Pharmaceutical research and development; scientific research, development, and analytical services in the field of pharmaceuticals, biopharmaceuticals, gene, genome, and cellular editing, modulation, and modification, and T-cell based therapeutics
avencell

General Information


Serial Number97773407
Word MarkAVENCELL
Filing DateMonday, January 30, 2023
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, July 16, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 21, 2024

Trademark Statements


Goods and ServicesPharmaceutical and biological preparations for the treatment of cancer and autoimmune diseases; pharmaceutical and biological preparations based on gene, genome, and cellular editing, modulation, and modification for use in human therapeutics for the treatment of cancer and autoimmune diseases; pharmaceutical preparations, namely, T-cell based therapeutics to treat cancer and autoimmune disease
Goods and ServicesPharmaceutical research and development; scientific research, development, and analytical services in the field of pharmaceuticals, biopharmaceuticals, gene, genome, and cellular editing, modulation, and modification, and T-cell based therapeutics

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, February 16, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, February 16, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAvenCell Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02138

Party NameAvenCell Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02138

Trademark Events


Event DateEvent Description
Thursday, February 2, 2023NEW APPLICATION ENTERED
Thursday, February 16, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 26, 2023ASSIGNED TO EXAMINER
Thursday, October 26, 2023NON-FINAL ACTION WRITTEN
Thursday, October 26, 2023NON-FINAL ACTION E-MAILED
Thursday, October 26, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, January 12, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Friday, April 5, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 5, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 5, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 17, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 12, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Wednesday, May 1, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 21, 2024PUBLISHED FOR OPPOSITION
Tuesday, May 21, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 16, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT